<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(3)</volume><submitter>Talaat KR</submitter><funding>Intramural NIH HHS</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The disease course of human immunodeficiency virus (HIV) is often altered by existing or newly acquired coincident infections.&lt;h4>Methodology/principal findings&lt;/h4>To assess the influence of pre-existing Wuchereria bancrofti infection on HIV progression, we performed a case-controlled treatment study of HIV positive individuals with (FIL+) or without (FIL-) W. bancrofti infection. Twenty-eight HIV+/FIL+ and 51 matched HIV+/FIL- subjects were treated with a single dose of diethylcarbamazine and albendazole (DEC/Alb) and followed for a year at regular intervals. Sixteen of the HIV+/FIL+ subjects (54%) and 28 of the HIV+/FIL- controls (57%) were on antiretroviral therapy (ART) during the study. Following treatment, no differences were noted in clinical outcomes between the</pubmed_abstract><journal>PLoS neglected tropical diseases</journal><pagination>e0003622</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4368731</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.</pubmed_title><pmcid>PMC4368731</pmcid><pubmed_authors>Babu S</pubmed_authors><pubmed_authors>Arumugam J</pubmed_authors><pubmed_authors>Dhakshinamurthy K</pubmed_authors><pubmed_authors>Fay MP</pubmed_authors><pubmed_authors>Swaminathan S</pubmed_authors><pubmed_authors>Poongulali S</pubmed_authors><pubmed_authors>Gu W</pubmed_authors><pubmed_authors>Talaat KR</pubmed_authors><pubmed_authors>Sharma J</pubmed_authors><pubmed_authors>Srinivasan R</pubmed_authors><pubmed_authors>Kumarasamy N</pubmed_authors><pubmed_authors>Menon P</pubmed_authors><pubmed_authors>Nutman TB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.</name><description>&lt;h4>Background&lt;/h4>The disease course of human immunodeficiency virus (HIV) is often altered by existing or newly acquired coincident infections.&lt;h4>Methodology/principal findings&lt;/h4>To assess the influence of pre-existing Wuchereria bancrofti infection on HIV progression, we performed a case-controlled treatment study of HIV positive individuals with (FIL+) or without (FIL-) W. bancrofti infection. Twenty-eight HIV+/FIL+ and 51 matched HIV+/FIL- subjects were treated with a single dose of diethylcarbamazine and albendazole (DEC/Alb) and followed for a year at regular intervals. Sixteen of the HIV+/FIL+ subjects (54%) and 28 of the HIV+/FIL- controls (57%) were on antiretroviral therapy (ART) during the study. Following treatment, no differences were noted in clinical outcomes between the</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Mar</publication><modification>2025-05-18T13:17:48.625Z</modification><creation>2025-05-18T13:17:48.625Z</creation></dates><accession>S-EPMC4368731</accession><cross_references><pubmed>25793933</pubmed><doi>10.1371/journal.pntd.0003622</doi></cross_references></HashMap>